Also found in: Thesaurus, Medical, Encyclopedia, Wikipedia.


(ˈnoʊl vəˌdɛks) Trademark.
a brand of tamoxifen.
References in periodicals archive ?
All respondents of anabolic-androgenic steroids (AAS) users indicated they usually taking oral substance indicting over twenty-five types of steroid were available, among these steroids type were; Growth Hormone (GH), Nolvadex, Amineptine, Deca, Dianabol, Ephedrine, Flyboy, Winstrol, Testosterone, Drive, Primoline, Stallone, Primobqlan, Nandrolone, Sastanon, amifepramone, bromantan, Amiphenazole, Etafedrine, Ethamivan, Terbutaline, Clenbuterol, Danazol, Bumbuterol, Salmeterol, Trenbolone, Depo-testosterone, and Anavar.
215) While the appeal was pending, the parties entered into a settlement under which Zeneca (which had succeeded ICI's ownership rights of the patent) would pay $21 million and grant Barr a non-exclusive license to sell Zeneca-manufactured Tamoxifen in the United States under Barr's label, rather than Zeneca's trademark Nolvadex.
Zeneca marketed its version of tamoxifen under the brand name Nolvadex.
Target medications generally dispensed through PBM services will include Imuran, Nolvadex, Plavix, Tabloid, Tegretol and Ziagen.
Key: SLE = Systemic lupus erythematosus Generic Name Trade Name Indication Toxic retinopathy Plaquenil Hydroxychloroquine Rheumatoid arthritis, SLE Tamoxyfen Nolvadex Breast cancer Vigabatrin Sabril Epilepsy anti-convulsant Chlorpromazine Largactil Anti-psychotic Desferrioxamine Desferal Anaemia Toxic optic neuropathy Ethambutol Isoniazid Rifina- Tuberculosis treatment Generic Name Visual side effect Toxic retinopathy Plaquenil Bull's eye maculopathy - blurred vision, altered colour Tamoxyfen Crystalline maculopathy - vision impaired if severe Vigabatrin Field restriction Chlorpromazine Blurred vision, abnormal colour (brownish tinge) Desferrioxamine Acuity reduction, scotomata, photopsia, metamorphopsia Toxic optic neuropathy Ethambutol Isoniazid Acuity and field loss, colourdefect-
Buzdar, received financial support from AstraZeneca, maker of anastrozole and of Nolvadex, a trademarked form of tamoxifen, which recently became a generic drug.
In 1993, as a result of a patent challenge, Barr and AstraZeneca entered into an agreement that resulted in the distribution by Barr of a more affordable version of AstraZeneca's Nolvadex (Tamoxifen Citrate) treatment for breast cancer.
Drugs with significant potential that are having generic equivalents hit the market are: Ortho-Novum 7/7/7 * (birth control) Ortho Tri-Clyclen * (birth control) Accupril (blood pressure) Nolvadex (breast cancer) Topamax (anti-convulsant) Glucophage XR (diabetes) Monopril (blood pressure) Remeron (antidepressant) Alphagan (glaucoma) Serzone (antidepressant) Glucovance (diabetes) Glucotrol XL (diabetes) Wellbutrin SR (antidepressant) Zyban (smoking cessation) Neurontin (anti-convulsant) Tiazac (blood pressure) Prozac (antidepressant) Prilosec (gastritis)
Chief executive Sir Tom McKillop said copy cat versions of its ulcer and heartburn treatment Prilosec,breast cancer drug Nolvadex and heart drug Zestril had knocked 1.
Competition from generic drugmakers in the United States for ulcer pill Prilosec, heart drug Zestril and cancer treatment Nolvadex took a large bite out of AstraZeneca's sales in the latest three months.
Chief executive Sir Tom McKillop said copycat versions of its ulcer and heartburn treatment Prilosec, breast cancer drug Nolvadex and heart drug Zestril had knocked $1.
Manufactured by Delaware-based AstraZeneca Pharmaceuticals, both Arimidex and Nolvadex - the brand-name version of tamoxifen - have been used to help reduce recurrence in women diagnosed with primary ductal carcinoma in situ (DCIS) breast cancer - characterized by the presence of cancer cells in the breast ducts, but not in nearby breast tissue or lymph nodes.